The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system
Kempken R, Büntemeyer H, Lehmann J (1991)
Cytotechnology 7(2): 63-74.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Autor*in
Kempken, Ralph;
Büntemeyer, HeinoUniBi;
Lehmann, Jürgen
Einrichtung
Abstract / Bemerkung
The perfusion mode of a continuous cell culture bioreactor was modified to establish a closed loop system. Eighty percent of the spent medium was re-used twice. The medium cycle bioreactor unit was operated sterile and uncomplicated without a technical retention system for the high molecular weight substances. Therefore, only 20% of the actual medium was necessary to run the recycling process. During seven days culture time in a two liter scale 5 grams of IgG 1 type monoclonal antibody was produced. During that period the cell specific productivity was constant. Renewal of proteins was omitted because the protein content in the system persisted at a high level. Therefore, self-conditioning substances of the cells were retained in the system as well as the expensive medium components (proteins with catalytic or stimulating function). Seventy to 80% of medium costs and medium quantity were saved for each medium recycling step. Only cheap metabolites that are consumed by the cells had to be supplemented. Uptake rates of glucose and amino acids were calculated to establish a suitable supplementation mixture for the recirculated medium.
Stichworte
recycling;
economy;
re-use;
supplementation;
medium
Erscheinungsjahr
1991
Zeitschriftentitel
Cytotechnology
Band
7
Ausgabe
2
Seite(n)
63-74
ISSN
1474-0338
Page URI
https://pub.uni-bielefeld.de/record/1782364
Zitieren
Kempken R, Büntemeyer H, Lehmann J. The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system. Cytotechnology. 1991;7(2):63-74.
Kempken, R., Büntemeyer, H., & Lehmann, J. (1991). The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system. Cytotechnology, 7(2), 63-74. https://doi.org/10.1007/BF00350912
Kempken, Ralph, Büntemeyer, Heino, and Lehmann, Jürgen. 1991. “The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system”. Cytotechnology 7 (2): 63-74.
Kempken, R., Büntemeyer, H., and Lehmann, J. (1991). The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system. Cytotechnology 7, 63-74.
Kempken, R., Büntemeyer, H., & Lehmann, J., 1991. The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system. Cytotechnology, 7(2), p 63-74.
R. Kempken, H. Büntemeyer, and J. Lehmann, “The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system”, Cytotechnology, vol. 7, 1991, pp. 63-74.
Kempken, R., Büntemeyer, H., Lehmann, J.: The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system. Cytotechnology. 7, 63-74 (1991).
Kempken, Ralph, Büntemeyer, Heino, and Lehmann, Jürgen. “The medium cycle bioreactor (MCB): monoclonal antibody production in a new economic production system”. Cytotechnology 7.2 (1991): 63-74.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Volltext(e)
Name
Access Level
Open Access
Zuletzt Hochgeladen
2019-09-06T08:48:46Z
MD5 Prüfsumme
361dc5349046d5f2aede65e3e5a0fa4d
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 1367908
PubMed | Europe PMC
Suchen in